These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3922776)

  • 41. Central dopaminergic properties of HW-165 and its enantiomers; trans-octahydrobenzo(f)quinoline congeners of 3-PPP.
    Hjorth S; Svensson K; Carlsson A; Wikström H; Andersson B
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Jul; 333(3):205-18. PubMed ID: 3762735
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Catecholamine receptor agonists: effects on motor activity and rate of tyrosine hydroxylation in mouse brain.
    Strömbom U
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(2):167-76. PubMed ID: 181681
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SCH 23390 may alter dopamine-mediated motor behaviour via striatal D-1 receptors.
    Boyce S; Kelly E; Davis A; Fleminger S; Jenner P; Marsden CD
    Biochem Pharmacol; 1985 May; 34(10):1665-9. PubMed ID: 2988552
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and dopaminergic properties of some exo- and endo-2-aminobenzonorbornenes designed as rigid analogue of dopamine.
    Burn P; Crooks PA; Heatley F; Costall B; Naylor RJ; Nohria V
    J Med Chem; 1982 Apr; 25(4):363-8. PubMed ID: 7200145
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The dopamine autoreceptor agonist B-HT 920 stimulates denervated postsynaptic brain dopamine receptors in rodent and primate models of Parkinson's disease: a novel approach to treatment.
    Hinzen D; Hornykiewicz O; Kobinger W; Pichler L; Pifl C; Schingnitz G
    Eur J Pharmacol; 1986 Nov; 131(1):75-86. PubMed ID: 3816949
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 6,7-Dihydroxy-3-chromanamine: synthesis and pharmacological activity of an oxygen isostere of the dopamine agonist 6,7-dihydroxy-2-aminotetralin.
    Horn AS; Kaptein B; Mulder TB; de Vries JB; Wynberg H
    J Med Chem; 1984 Oct; 27(10):1340-3. PubMed ID: 6090664
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 5-Oxygenated N-alkyl- and N,N-Dialkyl-2-amino-1-methyltetralins. Effects of structure and stereochemistry on dopamine-D2-receptor affinity.
    Grol CJ; Nordvall G; Johansson AM; Hacksell U
    J Pharm Pharmacol; 1991 Jul; 43(7):481-5. PubMed ID: 1682460
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alteration of striatal dopaminergic functions implicated in methamphetamine-induced reverse tolerance in rats.
    Kaneno S; Watanabe A; Takahashi R
    Eur J Pharmacol; 1986 Apr; 123(2):287-94. PubMed ID: 3086109
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
    Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of monoamine oxidase-B by (-)-deprenyl potentiates neuronal responses to dopamine agonists but does not inhibit dopamine catabolism in the rat striatum.
    Paterson IA; Juorio AV; Berry MD; Zhu MY
    J Pharmacol Exp Ther; 1991 Sep; 258(3):1019-26. PubMed ID: 1679846
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Behavioural and biochemical studies on 6-methylamino-4,5,6,7-tetrahydrobenzothiazole (14.839JL), a new potent dopaminergic agonist.
    Ponzio F; Algeri S; Garattini S; Cioce V; Rusconi L; Sacchetti G; Manuel C; Notelle C; Duvert L; Legeai J
    Pharmacol Res Commun; 1987 Aug; 19(8):555-65. PubMed ID: 3432322
    [TBL] [Abstract][Full Text] [Related]  

  • 52. S(-)DP-5,6-ADTN as an in vivo dopamine receptor ligand: relation between displacement by dopamine agonists and their pharmacological effects.
    Rollema H; Feenstra MG; Grol CJ; Lewis MH; Staples L; Mailman RB
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Apr; 332(4):338-45. PubMed ID: 3736679
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Selective acetylenic 'suicide' and reversible inhibitors of monoamine oxidase types A and B.
    Kalir A; Sabbagh A; Youdim MB
    Br J Pharmacol; 1981 May; 73(1):55-64. PubMed ID: 7284698
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and structural requirements of N-substituted norapomorphines for affinity and activity at dopamine D-1, D-2, and agonist receptor sites in rat brain.
    Gao YG; Ram VJ; Campbell A; Kula NS; Baldessarini RJ; Neumeyer JL
    J Med Chem; 1990 Jan; 33(1):39-44. PubMed ID: 2136919
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Potent dopamine agonist activity of a novel ergoline, 6-ethyl-9-oxaergoline (EOE).
    Martin GE; Williams M; Clineschmidt BV; Yarbrough GG; Jones JH; Haubrich DR
    Life Sci; 1982 May; 30(21):1847-56. PubMed ID: 7201555
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biochemical effects of minaprine on striatal dopaminergic neurons in rats.
    Ferretti P; Algeri S; Benfenati F; Cimino M; Ferretti C; Garattini S; Lipartiti M
    J Pharm Pharmacol; 1984 Jan; 36(1):48-50. PubMed ID: 6141265
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Certain dopamine agonists increase dopamine synthesis in the striatum of rat brain.
    Westerink BH; Feenstra MG; Wirix E; Horn AS
    Eur J Pharmacol; 1984 Jun; 101(3-4):235-41. PubMed ID: 6432559
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Kinetic properties of the in vivo accumulation of 3H-(-)-N-n-propylnorapomorphine in mouse brain.
    Ross SB; Jackson DM
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Jul; 340(1):13-20. PubMed ID: 2571943
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of drugs altering striatal dopamine levels on apomorphine induced stereotypy.
    Feigenbaum JJ; Yanai J; Blass RB; Moon B; Klawans H
    Pharmacol Biochem Behav; 1982 Feb; 16(2):235-40. PubMed ID: 7200236
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relationship between receptor occupancy and response at striatal dopamine autoreceptors.
    Meller E; Bohmaker K; Namba Y; Friedhoff AJ; Goldstein M
    Mol Pharmacol; 1987 Jun; 31(6):592-8. PubMed ID: 2885734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.